Advertisement

Pharmaceutisch Weekblad

, Volume 14, Issue 4, pp 185–190 | Cite as

Disposition of quinine in rats with induced renal failure

  • C. O. Onyeji
  • P. A. F. Dixon
  • N. C. Ugwu
Articles
  • 32 Downloads

Abstract

Aetiologically different models of experimental acute renal failure were induced in rats by the administration of glycerol, mercuric chloride and gentamicin, respectively, to different groups. Quinine levels in plasma and urine of the rats with induced renal failure were determined and pharmacokinetic parameters (eliminationt1/2, CL p ,V, CLR AUC0–∞) of the drug were derived and compared with values obtained from control rats following intraperitoneal administration of a 10 mg/kg body-weight dose of quinine. Results showed that each of the three compounds caused an up to 25-fold increase in the plasma levels of the drug and a marked decrease in the levels of the metabolite 3-hydroxyquinine. All the pharmacokinetic parameters determined for the rats with renal impairment were markedly different when compared to control. The high plasma quinine levels observed in the rats with renal failure could be largely due to the marked decrease inV and reduced metabolism. Also, in the rats with renal impairment, no correlation was observed between the increased plasma urea levels and plasma quinine levels or disposition of the drug. The results of the study suggest that quinine should be used with caution in patients with renal impairment. The plasma urea levels, as a measure of renal function, might not provide a suitable index for determining quinine dosage.

Keywords

Clearance Kidney failure Metabolites Pharmacokinetics Quinine Rats, laboratory 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fanke U, Prokesch B, Muller M, Risler T, Ehninger G. Drug monitoring of quinine by HPLC in cerebral malaria with acute renal failure treated with haemofiltration. Eur J Clin Pharmacol 1987;33:293–6.PubMedGoogle Scholar
  2. 2.
    Donadio JO, Whelton A, Kazyak L. Quinine therapy and peritoneal dialysis in acute renal failure complication malaria haemoglobinuria. Lancet 1968;1:375–9.PubMedGoogle Scholar
  3. 3.
    Canfield CJ, Miller LH, Bratellani PJ, Eichler P, Barry KC. Acute renal failure inPlasmodium falciparum malaria. Arch Intern Med 1968;122:199–203.PubMedGoogle Scholar
  4. 4.
    Trenholm GM, William RL, Rieckman LH, Frisher H, Carcon RE. Quinine disposition during malaria and induced fever. Clin Pharmacol Ther 1976;19:459–67.PubMedGoogle Scholar
  5. 5.
    White NJ, Looareesuwan S, Warrel DA, Warrel MJ, Bunnaq D, Harinasuta T. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 1982;73:564–71.PubMedGoogle Scholar
  6. 6.
    Grossman SH, Davis D, Kitshell DB, Shand DG, Reutledge PA. Diazepam and lidocaine plasma protein binding in renal diseases. Clin Pharmacol Ther 1982;31:350–7.PubMedGoogle Scholar
  7. 7.
    Mansor SM, Taylor TE, McGrath CS, Edwards G, Ward SA, Wirima JJ, et al. The safety and kinetics of intramuscular quinine in Malawian children with moderately severe falciparum malaria. Trans R Soc Trop Med Hyg 1990;84:482–7.PubMedGoogle Scholar
  8. 8.
    Berlin CM, Stackman JM, Vessell ES. Quinine induced alterations in drug disposition. Clin Pharmacol Ther 1975;18:670–9.PubMedGoogle Scholar
  9. 9.
    Mihaly GW, Ching MS, Klein MB, Paul J, Smallwood RA. Differences in the binding of quinine and quinidine to plasma proteins. Br J Clin Pharmacol 1987;24:769–74.PubMedGoogle Scholar
  10. 10.
    Fremstad D, Sten J, Per KM. Influence of serum protein binding on the pharmacokinetics of quinidine in normal and anuric rats. Acta Pharmacol Toxicol 1977;41:161–76.Google Scholar
  11. 11.
    Lin JH, Lin T. Renal handling of drugs in renal failure. 1. Differential effects of uranyl-nitrate and glycerol induced acute renal failure in renal excretion of TEAB and PAH in rats. J Pharmacol Exp Ther 1988;246:896–901.PubMedGoogle Scholar
  12. 12.
    Marsh WH, Fingerhut B, Miller H. Automated and manual direct methods for the determination of blood urea. Clin Chem 1965;11:624–7.PubMedGoogle Scholar
  13. 13.
    Bolaji OO, Babalola CP, Dixon PAF. Characterization of the principal metabolite of quinine in human urine by H-n.m.r. spectroscopy. Xenobiotica 1991;21:447–70.PubMedGoogle Scholar
  14. 14.
    Stein JH, Lifschitz MD, Barnes LO. Current concepts on the pathophysiology of acute renal failure. Am J Physiol 1978;234:F171–81.PubMedGoogle Scholar
  15. 15.
    Smith MW, Ambudkar IS, Phelps PC, Trump BF. Mercuric chloride-induced changes in systosolic Ca2+ of cultured rabbit renal tubular cells. Biochim Biophys Acta 1987;931:130–42.PubMedGoogle Scholar
  16. 16.
    Silverblatt FJ. Antibiotic nephrotoxicity. Urol Clin North Am 1975;2:557–67.PubMedGoogle Scholar
  17. 17.
    Kuhar MJ, Mak LL, Lietman PS. Autoradiographic localization of3H gentamicin in the proximal renal tubules of mice. Antimicrob Agents Chemother 1979;15:131–133.PubMedGoogle Scholar
  18. 18.
    Romero A, Grau A, Gartio A. Ultrastructural study in renal toxicity produced by aminoglycosides. Arch Pharmacol Toxicol 1981;7:25–30.Google Scholar
  19. 19.
    Barnes JC, McDowell EM, McNeil JS, Flamenbaun W, Trump BF. Studies on the pathophysiology of acute renal failure. IV. Protective effect of dithiothretol following administration of mercuric chloride in the rat. Virchows Arch 1980;B32:201–32.Google Scholar
  20. 20.
    Trifillis AL, Kahnq MW, Trump BF. Metabolic studies of mercuric chloride-induced acute renal failure in the rat. Exp Mol Pathol 1981;35:14–24.PubMedGoogle Scholar
  21. 21.
    White NJ, Looareesuwan S, Warrel DA. Quinine and quinidine. EKG comparison in the treatment of falciparum malaria. J Cardiovasc Pharmacol 1983;5:173–5.PubMedGoogle Scholar
  22. 22.
    Waller D, Krishna S, Craddock C, Brewster D, Jammeh A, Kwiatkoski D, et al. The pharmacokinetic properties of intramuscular quinine in Gambian children with severe falciparum malaria. Trans R Soc Trop Med Hyg 1990;84:488–91.PubMedGoogle Scholar
  23. 23.
    White NJ. The pharmacokinetics of quinine and quinidine in malaria. Acta Lerdensia 1987;55:65–76.Google Scholar
  24. 24.
    Silamut K, White NJ, Loouareesuwan S, Warrel DA. Binding of quinine to plasma protein in falciparum malaria. Am J Trop Med Hyg 1985;34:681–6.PubMedGoogle Scholar
  25. 25.
    Levy G. Pharmacokinetics in renal diseases. Am J Med 1977;62:461–6.PubMedGoogle Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1992

Authors and Affiliations

  • C. O. Onyeji
    • 1
  • P. A. F. Dixon
    • 2
  • N. C. Ugwu
    • 3
  1. 1.Department of Pharmaceutical Chemistry, Faculty of PharmacyObafemi Awolowo UniversityIle-IfeNigeria
  2. 2.Department of Pharmacology, Faculty of PharmacyObafemi Awolowo UniversityNigeria
  3. 3.Faculty of Health SciencesObafemi Awolowo UniversityNigeria

Personalised recommendations